| "Ramibacterium alactolyticum" Prevot and Taffanel 1942| "Ramibacterium dentium" Vinzent and Reynes 1947| "Ramibacterium pleuriticum" Prevot et al. 1947| ATCC 23263| CIP 106365| DSM 3980| Eubacterium alactolyticum| Eubacterium alactolyticum (Prevot and Taffanel 1942) Holdeman and Moore 1970 (Approved Lists 1980)| JCM 6480| Pseudoramibacter alactolyticus| Pseudoramibacter alactolyticus (Prevot and Taffanel 1942) Willems and Collins 1996| Ramibacterium alactolyticum| Ramibacterium dentium| Ramibacterium pleuriticum
Oral Microbiota: Pseudoramibacter alactolyticus is commonly found in the oral cavity, particularly in dental plaque and periodontal pockets. It is considered a part of the complex microbial community that makes up the oral microbiota.
Periodontal Health: Some studies have associated Pseudoramibacter alactolyticus with periodontal disease, a condition that involves inflammation of the supporting structures of the teeth, including the gums and bone. In individuals with periodontal disease, the composition of the oral microbiota can be altered, and certain bacteria, including Pseudoramibacter alactolyticus, may be more prevalent.
Halitosis (Bad Breath): Like many oral bacteria, Pseudoramibacter alactolyticus has been found in association with halitosis or bad breath. The production of certain volatile sulfur compounds by bacteria in the oral cavity contributes to unpleasant breath odor.
Systemic Health: While the primary impact of Pseudoramibacter alactolyticus appears to be localized in the oral cavity, there is ongoing research into the potential links between oral health and systemic health. Periodontal disease, in general, has been associated with conditions such as cardiovascular disease and diabetes.
Clinical Significance: The clinical significance of Pseudoramibacter alactolyticus in oral and systemic health is not fully elucidated, and more research is needed to understand its role, virulence factors, and potential contributions to disease.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.31 | 20 | 108 | 0 | 109 | 41.1 | 20 | 34.7 | 20 | 108 | 11.1 %ile | 77.8 %ile | ||
biomesight | 35.75 | 0 | 20 | 20 | 110 | 0 | 4606 | 401.4 | 30 | 2145.2 | 10 | 90 | 8 %ile | 90.5 %ile |
thryve | 15.43 | 0 | 9 | 1 | 35 | 0 | 7006 | 287.4 | 21 | 3428 | 9 | 41 | 0 %ile | 92 %ile |
ubiome | 0.25 | 65 | 375 | 0 | 650 | 220 | 220 | 219.2 | 65 | 375 | 25 %ile | 50 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 39.49 % | 0.039 % | 0.199 % | 1131.0 | 2864 |
BiomeSightRdp | 12.5 % | 0.003 % | 0.003 % | 4.0 | 32 |
custom | 3.39 % | 0.007 % | 0.006 % | 2.0 | 59 |
Thryve | 15.691 % | 0.024 % | 0.304 % | 217.0 | 1383 |
uBiome | 0.253 % | 0.022 % | 0.022 % | 2.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.